Advancing open science in Alzheimer’s disease clinical trials: Sharing of A4 and LEARN neuroimaging data

The Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration (LEARN) studies were large, multicenter investigations designed to characterize preclinical Alzheimer’s disease (AD) and evaluate whether solanezumab could slow cogni...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Gustavo A. Jimenez-Maggiora, Aaron P. Schultz, Michael C. Donohue, Hongmei Qiu, Reisa A. Sperling, Paul S. Aisen
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Organization for Human Brain Mapping 2026-05-01
סדרה:	Aperture Neuro
גישה מקוונת:	https://doi.org/10.52294/001c.160128
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!